Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer - Concepedia

Concepedia

Publication | Open Access

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer

DOI Full Paper Access

151

Citations

20

References

2009

Year

Egbert F. Smit, Sjaak A. Burgers, Bonne Biesma, Hans J.M. Smit, P Eppinga, Anne‐Marie C. Dingemans, Markus Joerger, Jan H.M. Schellens, Andrew Vincent, Nico van Zandwijk,

Journal of Clinical Oncology

Abstract

PC as second-line treatment for relapsed NSCLC resulted in a significant 33% reduction of the hazard of disease progression as compared with pemetrexed alone.

References

	Year	Citations

Page 1